Cogent Biosciences Inc.

5.71
-0.08 (-1.38%)
At close: Apr 02, 2025, 3:59 PM
5.41
-5.34%
After-hours: Apr 02, 2025, 06:15 PM EDT

Cogent Biosciences Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015
Net Income n/a -192.41M -140.24M -72.27M -74.81M -31.83M -34.53M -25.49M -18.12M -6.59M
Depreciation & Amortization n/a 3.59M 5.88M 147K 720K 1.29M 1.32M 1.17M 830K 179K
Stock-Based Compensation n/a 30.62M 18.37M 11.69M 6.02M 3.24M 3.09M 1.34M 1.02M 248K
Other Working Capital 10.24M 6.63M -1.61M -731K -1.31M -16.63M -3.9M -3.88M -2.86M 23.25M
Other Non-Cash Items -207.79M -6.87M -3.39M -343K 45.03M -131K 23K 7K -56K 248K
Deferred Income Tax n/a n/a n/a n/a -7.49M n/a -236K 17K 17K -248K
Change in Working Capital n/a 11.44M 751K 2.02M -5.32M -14.08M -2.15M -2.88M -2.32M 23.88M
Operating Cash Flow -207.79M -153.62M -118.64M -58.76M -35.85M -41.51M -32.49M -25.84M -18.64M 17.72M
Capital Expenditures n/a -2.8M -6.86M -1.72M n/a -33K -549K -912K -3.31M -1.99M
Acquisitions n/a n/a 117.86K n/a 8.42M 204K n/a n/a n/a n/a
Purchase of Investments n/a -348.8M -177.85M n/a n/a -204K -47.68M -6.5M -55.17M n/a
Sales Maturities Of Investments n/a 253.78M 60M n/a n/a 22.99M 37.7M 21M 28M n/a
Other Investing Acitivies 38.28M n/a -117.86K n/a 8.42K 204K n/a -75K 50K -1.25M
Investing Cash Flow 38.28M -97.82M -124.72M -1.72M 8.42M 23.16M -10.53M 13.51M -30.43M -3.25M
Debt Repayment n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies 1.11M n/a 1.61M -30K 560K 108K -1.45M -789K -40K n/a
Financial Cash Flow 214.45M 163.54M 163.56M 37.98M 232.2M 108K 70.35M -729K -40K 70.75M
Net Cash Flow 44.94M -87.91M -79.8M -22.51M 204.77M -18.25M 27.33M -13.05M -49.11M 85.22M
Free Cash Flow -207.79M -156.42M -125.5M -60.48M -35.85M -41.55M -33.04M -26.75M -21.95M 15.72M